| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥223.3B | ¥200.5B | +11.4% |
| Operating Income | ¥24.2B | ¥17.5B | +38.3% |
| Ordinary Income | ¥24.6B | ¥18.8B | +30.8% |
| Net Income | ¥16.5B | ¥12.7B | +29.5% |
| ROE | 7.7% | 6.1% | - |
FY2026 Q2 results show strong revenue growth and operating leverage improvements. Revenue reached 223.3 billion yen (YoY +11.4%), with Operating Income of 24.2 billion yen (+38.3%), Ordinary Income of 24.6 billion yen (+30.8%), and Net Income of 16.5 billion yen (+29.5%). Operating margin expanded to 10.9% from the prior period, reflecting improved operational efficiency despite gross margin of 19.0% remaining below industry benchmarks. The company continues aggressive growth investments with capital expenditures of 20.2 billion yen while maintaining a high dividend payout ratio of 67.6%. Short-term liquidity indicators warrant attention, with current ratio at 87.5% and working capital at negative 3.0 billion yen.
[Profitability] ROE of 7.7% reflects improvement driven primarily by net profit margin expansion to 7.4%, combined with asset turnover of 0.42 times and financial leverage of 2.49 times. Operating margin improved to 10.9% (YoY +approximately 1.2pt from estimated 9.7%), demonstrating enhanced operational efficiency. Gross margin stands at 19.0%, remaining below the industry reference level of approximately 20%, indicating room for improvement in pricing power and cost management. EBIT margin of 10.9% positions within the favorable industry range of 8-15%. [Cash Quality] Cash and equivalents of 76.3 billion yen provide coverage of 1.31 times against short-term debt of 58.1 billion yen. Operating cash flow of 23.7 billion yen represents 1.44 times net income, confirming strong cash-backed earnings quality. OCF to EBITDA conversion stands at 0.80 times, approaching industry benchmarks with room for working capital optimization. [Investment Efficiency] Total asset turnover of 0.42 times reflects the capital-intensive nature of the nursing care business. Capital expenditure intensity reached 3.76 times depreciation at 20.2 billion yen, indicating active growth investment phase. Days sales outstanding of 65 days exceeds the 60-day reference threshold, suggesting working capital management requires attention. [Financial Health] Equity ratio of 40.2% (213.7 billion yen equity against 531.8 billion yen total assets), current ratio of 87.5% falls below the 100% threshold with working capital at negative 3.0 billion yen, indicating short-term liquidity constraints. Interest-bearing debt totals 115.0 billion yen with debt-to-equity ratio of 0.54 times. Debt-to-EBITDA of 3.88 times represents moderate leverage, while interest coverage ratio of 42.5 times demonstrates comfortable debt servicing capacity. Short-term debt represents 50.5% of total debt, warranting attention to refinancing risk management.
Operating cash flow of 23.7 billion yen represents 1.44 times net income, confirming healthy cash generation quality from core operations. The positive OCF-to-income ratio indicates earnings are well-supported by actual cash inflows despite working capital remaining at negative 3.0 billion yen. Investing cash flow of 20.2 billion yen was primarily directed toward capital expenditures, with CapEx-to-depreciation ratio of 3.76 times signaling aggressive expansion investments. This resulted in free cash flow of 1.9 billion yen, substantially constrained by growth investment requirements. Financing cash flow considerations include dividend payments with payout ratio of 67.6%, which significantly exceeds the limited FCF generation, resulting in FCF coverage of dividends at 0.18 times. Working capital dynamics show elevated days sales outstanding at 65 days, suggesting collection cycle efficiency requires improvement to enhance cash conversion. Contract liabilities of 126.5 billion yen represent substantial advance revenue recognition, characteristic of the nursing care business model, providing visibility into future revenue streams. Cash position of 76.3 billion yen provides 1.31 times coverage against short-term debt obligations, maintaining basic liquidity adequacy despite the low current ratio.
Ordinary income of 24.6 billion yen versus operating income of 24.2 billion yen shows non-operating net contribution of approximately 0.4 billion yen, representing 0.2% of revenue and indicating earnings are predominantly driven by core operations. The non-operating segment includes interest and dividend income alongside financial items, with interest burden coefficient of 1.012 demonstrating minimal dilution from financing costs. Operating income margin of 10.9% compared to net income margin of 7.4% reflects an effective tax rate of approximately 32.9% as indicated by tax burden coefficient of 0.671, which is moderately elevated but within reasonable ranges. Operating cash flow exceeding net income at 1.44 times confirms strong earnings quality with minimal accrual concerns. The gross margin of 19.0% trailing industry benchmarks suggests pricing pressure or cost structure challenges that may constrain earnings quality sustainability if unaddressed. Depreciation of 5.37 billion yen against capital expenditures of 20.2 billion yen indicates substantial investments in long-term productive capacity, with future earnings dependent on successful deployment of these assets. Contract liabilities of 126.5 billion yen provide earnings visibility through deferred revenue recognition, supporting revenue quality through advance customer commitments.
Liquidity Management Risk: Current ratio of 87.5% combined with short-term debt representing 50.5% of total liabilities creates potential refinancing pressure. Working capital at negative 3.0 billion yen and days sales outstanding at 65 days indicate collection efficiency challenges that could strain liquidity if operating conditions deteriorate or payment terms extend further.
Margin Compression Risk: Gross margin of 19.0% remains below industry reference levels of approximately 20%, exposing the company to profitability pressure from rising input costs or competitive pricing dynamics. The nursing care segment operating margin, while improved, requires sustained pricing power and operational efficiency gains to maintain current profitability trajectory amid potential labor cost inflation and regulatory changes.
Dividend Sustainability Risk: Dividend payout ratio of 67.6% significantly exceeds free cash flow generation, with FCF coverage of dividends at only 0.18 times. Current dividend policy at 34.0 yen per share period-end (17.0 yen annual forecast) relies heavily on operating cash flow rather than free cash flow, creating potential strain on financial flexibility if capital investment requirements persist or operating cash generation weakens.
[Industry Position] (Reference - Proprietary Analysis) The nursing care services industry in Japan operates with characteristic features including contracted revenue models, regulatory pricing frameworks, and labor-intensive operations. Charm Care Corporation demonstrates revenue growth of 11.4% outpacing typical industry growth rates of 3-5%, reflecting successful facility expansion and occupancy gains. The company's operating margin of 10.9% positions within the industry's favorable performance range of 8-15%, though gross margin of 19.0% suggests room for improvement relative to efficient operators achieving 20-22% gross margins. ROE of 7.7% reflects moderate capital efficiency typical of asset-heavy nursing care operators where industry participants generally achieve 6-9% ROE. The company's debt-to-EBITDA of 3.88 times represents moderate leverage within the sector where operators typically maintain 3.0-4.5 times ratios to balance growth financing with financial stability. Current ratio of 87.5% falls below preferred industry thresholds of 100-120%, as nursing care operators typically maintain stronger liquidity buffers given working capital requirements and regulatory compliance obligations. The company's capital expenditure intensity at 3.76 times depreciation exceeds typical industry replacement rates of 1.0-1.5 times, positioning as growth-focused expansion strategy. Contract liabilities representing substantial advance payments align with industry business models where entrance fees and prepaid service arrangements provide operational funding. Overall positioning reflects an aggressive growth posture with solid operating margins but requiring attention to gross margin optimization and balance sheet liquidity strengthening.
Revenue Growth Momentum Supported by Business Model Characteristics: The company achieved 11.4% revenue growth with full-year guidance projecting 4.1% growth, demonstrating sustained expansion trajectory. Contract liabilities of 126.5 billion yen, representing advance customer commitments, provide substantial visibility into future revenue streams and occupancy stability. The nursing care segment generating 21.3 billion yen in sales with operating income of 3.0 billion yen (14.1% segment margin) indicates solid unit economics. This growth profile, combined with aggressive capital deployment at 3.76 times depreciation replacement rates, positions the company in active facility network expansion phase. The sustainability of this growth depends on successful deployment of invested capital and maintenance of occupancy rates across existing and new facilities.
Operating Leverage Realization Requiring Balance Sheet Optimization: Operating margin expansion to 10.9% with operating income growth of 38.3% significantly outpacing revenue growth of 11.4% demonstrates effective operating leverage as fixed cost absorption improves across the facility network. However, gross margin of 19.0% remaining below industry benchmarks and days sales outstanding extending to 65 days indicate operational efficiency opportunities. Working capital at negative 3.0 billion yen and current ratio of 87.5% create short-term liquidity constraints that may limit strategic flexibility. The company generates strong operating cash flow at 1.44 times net income, but free cash flow of only 1.9 billion yen against dividend requirements and ongoing expansion needs suggests balance sheet optimization through improved working capital management and potentially adjusted capital allocation priorities would enhance financial resilience. Interest coverage of 42.5 times provides comfortable debt servicing capacity, but short-term debt concentration at 50.5% of total debt requires proactive refinancing management to avoid maturity mismatches.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.